| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/04/1994 | US5275824 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 01/04/1994 | US5275823 Histamine H2 receptor antagonists containing cimetidine |
| 01/04/1994 | US5275822 Dry, uniform, free-flowing granular carbohydrate agglomerate; hydrocarbon, mineral or silicone oils containing silica |
| 01/04/1994 | US5275821 Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
| 01/04/1994 | US5275820 Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles |
| 01/04/1994 | US5275819 Drug loaded pollen grains with an outer coating for pulsed delivery |
| 01/04/1994 | US5275806 Topical compositions for protection against ultraviolet radiation |
| 01/04/1994 | CA2099556A1 2-amino-n-¬¬¬4-(aminocarbonyl)pyrimidin-2-yl|amino|alkyl| pyrimidine-4-carboxamide derivatives, preparation thereof and therapeutical application thereof |
| 01/04/1994 | CA1325769C Sustained release protein compositions and method for making |
| 01/04/1994 | CA1325707C Granular tricalcium phosphate compositions suitable for direct compression tableting |
| 12/29/1993 | EP0576377A1 Microcapsules containing at least an active principle, their applications and one of their processes of preparation |
| 12/29/1993 | EP0576279A1 Hydrophilic cream for the delivery of therapeutic agents |
| 12/29/1993 | EP0575977A2 Chewing gum compositions |
| 12/29/1993 | EP0575976A1 Inclusion complexes of polymerized cyclodextrins with pharmaceutical drugs |
| 12/29/1993 | EP0575930A1 Process for the preparation of solid sustained release pharmaceutical forms |
| 12/29/1993 | EP0575841A1 Composition containing dibucaine hydrochloride, a salicylate, calcium bromide and an antiphlopstic steroid for the treatment of pain |
| 12/29/1993 | EP0575613A1 Pharmaceutical preparation of antistress, stress-preventive and nootropic action |
| 12/29/1993 | EP0575595A1 Hair spray aerosol system |
| 12/29/1993 | EP0575524A1 Method and products for treating the eye |
| 12/29/1993 | EP0575454A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof. |
| 12/29/1993 | EP0575439A1 Granules and veterinary compositions comprising a water-soluble complex of flumequine |
| 12/29/1993 | EP0575373A1 Topical soap-gel preparation |
| 12/29/1993 | EP0496824B1 Reconstitution method |
| 12/29/1993 | EP0429442B1 Dental therapy by vesicle delivery |
| 12/29/1993 | EP0418248B1 Transdermal multipolymer drug delivery system |
| 12/29/1993 | EP0396549B1 A drug composition with microspheres and process for its preparation |
| 12/29/1993 | EP0358677B1 Multiwall polymeric microcapsules |
| 12/29/1993 | CN1079954A Novel compound |
| 12/29/1993 | CN1079896A Topical aromatic releasing compositions |
| 12/29/1993 | CN1023295C Method and composition for prophylaxis and treatment of viral infections |
| 12/29/1993 | CN1023294C Surgical application base for curing wound and preparing process thereof |
| 12/29/1993 | CN1023293C Controlling-release preparation |
| 12/28/1993 | US5273965 A reduced and hydrolyzed saponin from a Quillaja saponaria extract |
| 12/28/1993 | US5273953 Pesticidal compositions comprising ethoxylated citric or tartaric acid derivatives as stabilizing surfactants |
| 12/28/1993 | US5273760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 12/28/1993 | US5273758 Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms |
| 12/28/1993 | US5273757 Apparatus for the delivery of substances, processes for the production thereof and use thereof |
| 12/28/1993 | US5273756 A backing, a pressure-rupturable reservoir, adsorbent wick, drug-permeable polymer adhesive, an unplasticized microporous membrane, and a drug-permeable membrane |
| 12/28/1993 | US5273755 Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset |
| 12/28/1993 | US5273752 Controlled release dispenser comprising beneficial agent |
| 12/28/1993 | US5273742 Replacing ocular fluid in a mammal eye using an aqueous solution of hydrogel polyoxyethylene glycol polyurethane; nontoxic |
| 12/28/1993 | US5273056 Use of combinations of viscoelastics during surgery |
| 12/28/1993 | CA1325600C Anticariogenic compositions |
| 12/28/1993 | CA1325590C Concentrated stabilized microbubble-type ultrasonic imaging agent |
| 12/27/1993 | CA2096690A1 Hydrophilic creams for delivery of therapeutic agents |
| 12/23/1993 | WO1993026019A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
| 12/23/1993 | WO1993025673A1 In vivo gene therapy with intron-free sequence of interest |
| 12/23/1993 | WO1993025660A1 System and method for transplantation of cells |
| 12/23/1993 | WO1993025583A2 Proteinoid carriers and methods for preparation and use thereof |
| 12/23/1993 | WO1993025547A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 12/23/1993 | WO1993025246A1 Prosthetic devices having enhanced osteogenic properties |
| 12/23/1993 | WO1993025242A1 Microparticles, method of producing them and their use for diagnostic purposes |
| 12/23/1993 | WO1993025241A1 Use of microcapsules as contrasting agents in colour doppler sonography |
| 12/23/1993 | WO1993025234A1 Methods and compositions for targeting specific tissue |
| 12/23/1993 | WO1993025231A1 Use of zona pellucida glycoproteins for immunocontraception |
| 12/23/1993 | WO1993025225A1 Liposomal formulations for administering to cancer patients |
| 12/23/1993 | WO1993025224A1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer |
| 12/23/1993 | WO1993025222A1 Stabilized somatotropin for parenteral administration |
| 12/23/1993 | WO1993025221A1 Erythropoietin drug delivery system |
| 12/23/1993 | WO1993025209A1 Compositions for the treatment and prophylaxis of inflammations and dermatoses induced by viruses and process for the preparation thereof |
| 12/23/1993 | WO1993025206A1 ORALLY ADMINISTRABLE COMPOSITION OF PYRIDO[1,2-a]PYRIMIDINE DERIVATIVE |
| 12/23/1993 | WO1993025204A1 Gastro-protected stable omeprazole compositions in the form of microgranules and process for their production |
| 12/23/1993 | WO1993025198A1 Ultrafine powder for inhalation and production thereof |
| 12/23/1993 | WO1993025197A1 Compositions and methods for enhanced drug delivery |
| 12/23/1993 | WO1993025195A1 Preparation and use of novel cyclodextrin-based dispersible colloidal systems in the form of nanospheres |
| 12/23/1993 | WO1993025194A1 Preparation and use of novel cyclodextrin-based dispersible nanovesicular colloidal systems in the form of nanocapsules |
| 12/23/1993 | WO1993025193A1 Pharmaceutical preparation for intra-airway administration |
| 12/23/1993 | WO1993025192A1 Pharmaceutical compositions containing nsaid and bile acids |
| 12/23/1993 | WO1993025191A2 Bioresorbable polymer microspheres free from surface active agents, their preparation and application as drug |
| 12/23/1993 | WO1993025190A1 Surface modified nsaid nanoparticles |
| 12/23/1993 | WO1993025189A1 Burn foam and delivery system |
| 12/23/1993 | WO1993025187A1 Combinations of viscoelastics for use during surgery |
| 12/23/1993 | WO1993025168A1 The use of glycerin in moderating transdermal drug delivery |
| 12/23/1993 | WO1993025085A1 Water-soluble, instant tea product |
| 12/23/1993 | CA2138146A1 Proteinoid carriers and methods for preparation and use thereof |
| 12/23/1993 | CA2138010A1 Microparticles, method of producing them and their use for diagnostic purposes |
| 12/23/1993 | CA2137914A1 System and method for transplantation of cells |
| 12/23/1993 | CA2137145A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
| 12/23/1993 | CA2096004A1 Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered bile acids |
| 12/22/1993 | EP0574894A1 Composition of gastric acid - resistant microspheres containing buffered bile acids |
| 12/22/1993 | EP0574822A1 Pharmaceutical soft capsules containing lysin clonixinate and method to produce them |
| 12/22/1993 | EP0574624A1 Pharmaceutical compositions |
| 12/22/1993 | EP0574571A1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| 12/22/1993 | EP0574504A1 Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same |
| 12/22/1993 | EP0444194B1 Agent for thermotherapy |
| 12/22/1993 | EP0413016B1 Novel compositions containing hyaluronic acid associates and a process for preparing same |
| 12/22/1993 | CN1079757A Yeast debris products |
| 12/22/1993 | CN1079650A New use of nicotinic acid and its derivative |
| 12/22/1993 | CN1023229C Stable mixture containing oxidation-sensitive compounds, its prepn. and application |
| 12/22/1993 | CN1023191C Process for producing sustained release ibuprofen preparation |
| 12/21/1993 | US5272137 Aqueous pharmaceutical suspension for pharmaceutical actives |
| 12/21/1993 | US5272135 Method for the stabilization of methionine-containing polypeptides |
| 12/21/1993 | US5272079 Purification and administration of DNA repair enzymes |
| 12/21/1993 | US5271961 Method for producing protein microspheres |
| 12/21/1993 | US5271946 Controlled release azelastine-containing pharmaceutical compositions |
| 12/21/1993 | US5271945 Sustained release microcapsule for water soluble drug |
| 12/21/1993 | US5271944 Pharmacologically enhanced formulations |
| 12/21/1993 | US5271942 Agent for reducing the growth of or removing the hair on the human body |
| 12/21/1993 | US5271940 Transdermal delivery device having delayed onset |
| 12/21/1993 | US5271939 Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |